Intelligent Bio Solutions Inc.
INBS
$2.15
-$0.05-2.27%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -30.36% | 19.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -30.36% | 19.85% | |||
| Cost of Revenue | -26.85% | 699.20% | |||
| Gross Profit | -35.67% | -57.48% | |||
| SG&A Expenses | -7.18% | -27.02% | |||
| Depreciation & Amortization | 1.60% | 5.59% | |||
| Other Operating Expenses | -5.95% | -61.87% | |||
| Total Operating Expenses | -20.17% | 1.64% | |||
| Operating Income | 16.91% | 3.07% | |||
| Income Before Tax | 16.25% | 3.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.25% | 3.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -20.65% | -17.12% | |||
| Net Income | 16.24% | 3.54% | |||
| EBIT | 16.91% | 3.07% | |||
| EBITDA | 18.77% | 3.88% | |||
| EPS Basic | 29.63% | 23.04% | |||
| Normalized Basic EPS | 29.60% | 23.02% | |||
| EPS Diluted | 29.63% | 23.04% | |||
| Normalized Diluted EPS | 29.60% | 23.02% | |||
| Average Basic Shares Outstanding | 19.02% | 25.34% | |||
| Average Diluted Shares Outstanding | 19.02% | 25.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
